Consistent with previous analyses in older persons without CKD, cystatin C is a superior prognostic biomarker for the risk of death, cardiovascular disease, and CKD compared to serum creatinine and eGFR [14,25]. This evidence concerns the gene CST3 and cardiovascular disorder.